Royal Adelaide Hospital/Institute of Medical and Veterinary Science, South Australia Health, Government of South Australia, Adelaide, Australia.
Maturitas. 2011 Mar;68(3):279-85. doi: 10.1016/j.maturitas.2010.12.007. Epub 2011 Jan 17.
The role of endogenous testosterone in the pathogenesis of type 2 diabetes mellitus remains vague. We investigated whether associations between endogenous testosterone and diabetes prevalence in men could be partially explained by modifiable risk factors.
A random population-based cross-sectional study of 1195 men aged 35-80 years living in the north-west regions of Adelaide, Australia. Data collections occurred between 2002 and 2005, and response rate was 45.1%.
Diabetes (non-specific) was classified by either: (1) self-report for doctor diagnosis of diabetes; (2) prescription medication for diabetes; (3) fasting plasma glucose ≥ 7 mmol/L; or (4) glycosylated haemoglobin ≥ 6.2%. Logistic regressions were used to estimate odds ratios (OR [with 95% confidence intervals]) for diabetes, with stepwise adjustments for demographic, lifestyle, and clinical factors.
Diabetes prevalence was positively associated with age groups 45-54 years (2.8 [1.4, 5.8]), 55-64 years (3.9 [1.9, 8.3]) and ≥ 65 years (4.0 [1.8, 8.9]), lowest income group (1.8 [1.0, 3.4]), ex-smoker (1.8 [1.2, 2.9]), lowest (3.2 [1.9, 5.5]) and middle (1.9 [1.1, 3.4]) alcohol tertiles, cardiovascular disease (1.9 [1.2, 2.8]), metabolic syndrome (4.0 [2.6, 6.1]), and lowest plasma total testosterone tertile (1.8 [1.1, 3.0]), but negatively associated with middle (0.5 [0.3, 0.8]) and highest (0.4 [0.3, 0.7]) sugar intake tertiles, arthritis (0.6 [0.3, 1.0]), and elevated LDL cholesterol (0.5 [0.3, 0.8]); ORs showed an inverted 'U' shape for middle and highest voiding lower urinary tract symptoms tertiles. Body composition, muscle strength, and cardio-metabolic factors partially explained the association between low plasma total testosterone and diabetes.
Plasma total testosterone was inversely and independently associated with diabetes prevalence, that might have been partially explained by several modifiable risk factors.
内源性睾丸酮在 2 型糖尿病发病机制中的作用仍不明确。我们研究了男性内源性睾丸酮与糖尿病患病率之间的关联是否可以部分用可改变的危险因素来解释。
这是一项针对居住在澳大利亚阿德莱德西北部的 1195 名 35-80 岁男性的随机人群基础横断面研究。数据收集于 2002 年至 2005 年之间,应答率为 45.1%。
糖尿病(非特异性)通过以下方式分类:(1)自我报告医生诊断为糖尿病;(2)糖尿病处方药物;(3)空腹血糖≥7mmol/L;或(4)糖化血红蛋白≥6.2%。使用逻辑回归来估计糖尿病的比值比(OR[95%置信区间]),逐步调整人口统计学、生活方式和临床因素。
糖尿病患病率与 45-54 岁(2.8[1.4,5.8])、55-64 岁(3.9[1.9,8.3])和≥65 岁(4.0[1.8,8.9])年龄组、最低收入组(1.8[1.0,3.4])、前吸烟者(1.8[1.2,2.9])、最低(3.2[1.9,5.5])和中间(1.9[1.1,3.4])酒精三分位数、心血管疾病(1.9[1.2,2.8])、代谢综合征(4.0[2.6,6.1])和最低血浆总睾丸酮三分位数(1.8[1.1,3.0])呈正相关,但与中间(0.5[0.3,0.8])和最高(0.4[0.3,0.7])糖摄入量三分位数、关节炎(0.6[0.3,1.0])和升高的 LDL 胆固醇(0.5[0.3,0.8])呈负相关;OR 显示中间和最高排尿下尿路症状三分位数呈倒“U”形。血浆总睾丸酮与糖尿病患病率呈负相关且独立相关,这可能部分与几个可改变的危险因素有关。